StockDriftsStockDriftsTop 12 Oup Management Co., Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | 42.74% | 2.94M | $19.0M | +0.00%(+0) | — | 2023-09-30 | |
| AVTE | Aerovate Therapeutics Inc. | 18.43% | 603.8K | $8.2M | +0.00%(+0) | — | 2023-09-30 | |
| CYTT | Cyteir Therapeutics, Inc. | 15.71% | 2.46M | $7.0M | +0.00%(+0) | — | 2023-09-30 | |
| PMVP | PMV Pharmaceuticals, Inc. | 13.66% | 989.2K | $6.1M | +0.00%(+0) | — | 2023-09-30 | |
| GRPH | Graphite Bio | 2.27% | 406.3K | $1.0M | +0.00%(+0) | — | 2023-09-30 | |
| RNAC | Selecta Biosciences, Inc. | 2.06% | 862.5K | $914K | +0.00%(+0) | — | 2023-09-30 | |
| VOR | Vor Biopharma Inc. | 1.79% | 374.7K | $794K | +0.00%(+0) | — | 2023-09-30 | |
| EFTR | eFFECTOR Therapeutics, Inc. | 1.38% | 1.03M | $615K | +0.00%(+0) | — | 2023-09-30 | |
| DTIL | Precision BioSciences, Inc. | 0.86% | 1.12M | $384K | +0.00%(+0) | — | 2023-09-30 | |
| SPRO | Spero Therapeutics, Inc. | 0.68% | 249.1K | $301K | +0.00%(+0) | — | 2023-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Oup Management Co., Llc reports $44.47M in US-listed equity holdings across 12 positions in its most recent 13F filing. Its largest disclosed positions are CNTA (42.7%), AVTE (18.4%) and CYTT (15.7%). Figures reflect the Q3 2023 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Oup Management Co., Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Oup Management Co., Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1880124). View Oup Management Co., Llc’s 13F filings on SEC